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294 Survey of contraceptive practices in women attending a large
regional UK centre
C. Etherington1, S. Huntington1, S.P. Conway1, D. Peckham1. 1Regional Adult
Cystic Fibrosis Unit, St James’s University Hospital, Leeds, United Kingdom
Introduction: Women with CF have similar sexual lifestyles to their peers and
most are fertile. With improved survival it is vital that effective contraception and
sexual health choices are made.
Aim: To determine the number of women using any form of contraception, the
different methods used and the source of their sexual health advice.
Methods: A survey was performed between July and November 2011. Clinical and
demographic data was retrieved from computer records (age, BMI, FEV1, presence
of CFRD, pancreatic insufﬁciency (PI) and transplant status).
Results: 150 (92%) women were questioned. Median (range) age 28 (17−90) yrs,
FEV1 62 (14–113) % predicted, BMI 21.3 (15.3–41.2). 88% were PI, 36% had
CFRD and 15% post lung transplant. 60 women were not using any form of con-
traception; 28 had a valid reason but 32 women (21%) did not. This ﬁgure is lower
than previously reported (30−50%). The commonest form of contraception used was
OCP (34%), followed by condoms (20%), depot Injection (17%), implant (13%),
coil (10%), tubal ligation (4%), hysterectomy (1%), partner vasectomy (1%).
Depot/implant users were signiﬁcantly younger (median age 21 yrs) than those using
OCP (26 yrs), coil (27 yrs) and condoms (33 yrs), p< 0.05. 50% of women received
contraceptive advice from their GP and only 17% from the CF team.
Conclusions: This is the largest review to date of contraceptive practices in women
with CF. The majority are making active choices however 1 in 5 women are not.
Documentation of contraceptive choice is an essential part of reproductive health
counseling to reduce risk of unplanned pregnancy. CF teams need training in the
full range of contraceptive methods available.
295 Pregnancy outcomes in female cystic ﬁbrosis patients attending
an adult CF center
C.M. Carroll1, C.G. Gallagher1, E. McKone1. 1St. Vincent’s University Hospital,
National Referral Center for Adult Cystic Fibrosis, Dublin, Ireland
Background: With improved survival, pregnancy and motherhood is now a much
more realistic option for many women with cystic ﬁbrosis. The purpose of this
study was to review our experience of pregnancy in a large adult cystic ﬁbrosis
center.
Method: Study design was a retrospective cohort study, with clinical data abstracted
from patients medical notes. Variables of interest included age at most recent
pregnancy, FEV1 (%predicted) and BMI pre-pregnancy and at end of follow-up,
diabetic status, CFTR genotype and presence of pancreatic sufﬁciency.
Results: A total of 21 females were included in the study. Average follow-up was
8 years. Three patients died during the follow-up period. A total of 35 babies were
born to 21 CF mothers (range 1−5 pregnancies per person). There were two sets of
twins. Mean age at most recent pregnancy was 30 years old (range 21−38). Patients’
FEV1 varied in severity from 24%–105% predicted. Only 12 (54%) women had
a severe CFTR genotype (two class I−III mutations) which is much lower than
the CF population attending the CF center. Twenty-nine percent were pancreatic
sufﬁcient. Two women had CF related diabetes prior to becoming pregnant.
Eighteen women conceived naturally with 2 requiring intrauterine injection and
one underwent IVF resulting in the birth of twins.
Interpretation: Pregnancy in women with CF is common and has successful
outcomes even in patients with very advanced CF lung disease.
296 Why do adult patients with cystic ﬁbrosis attend their general
practitioner? A specialist CF centre’s perspective
E. McSwiney1, O. O’Connell1, C. Fleming1, C. Shortt1, D.M. Murphy1, B. Plant1.
1Cork University Hospital, Cork Adult Cystic Fibrosis Centre, Cork, Ireland
Background: Little is known as to how patients with CF access primary care
medicine in the era of specialist centre care. A recent eighty-two page Health
Service Executive (HSE) publication entitled ‘Services for People with Cystic
Fibrosis in Ireland’ brieﬂy mentioned the role of general practitioner (GP) only
3 times.
Method: Following ethical approval, we used a departmental-designed question-
naire to determine this relationship.
Results: 73 patients responded to the questionnaire, representing a response rate of
57%. The mean (SD) age was 28 (9) years and FEV1 63 (23)%. Despite quarterly
CF outpatient clinic visits 92% of CF patients attended their GP at least once during
the previous year, with 45% attending at least three times. 86% of CF patients who
attended their GP did so for annual inﬂuenza vaccination, with 45% attending for
prescription renewal, 18% for contraceptive advice, 10% for a CF exacerbation,
and 6% for the treatment of mood problems. While 66% of CF patients felt their
GP had a good knowledge of CF, only 23% reported their GP to make speciﬁc
arrangements to prevent cross-infection for the purpose of their consultation. The
majority (86%) of CF patients preferred to attend the CF day unit for management
of a suspected CF exacerbation and this preference was independent of the distance
needed to travel to the day unit, up to a distance of 140 kilometres.
Conclusion: CF patients rely on Primary Care for essential services. This is
particularly the case in the areas of sexual and mental health. Greater collaboration
is required to support enhanced CF speciﬁc education strategies in Primary Care.
297 Health care professionals’ appreciation of the challenges of
concordance to therapies in CF
L. Morrison1, G. MacGregor2. 1West of Scotland Adult CF Unit, Physiotherapy,
Glasgow, United Kingdom; 2West of Scotland Adult CF Unit, Respiratory Medicine,
Glasgow, United Kingdom
Introduction: Adherence to therapies is a major challenge in CF. The treatment
burden often involves inhaled and oral medication, physiotherapy and exercise. This
study was devised to inform Health Care Professionals (HCPs) of the difﬁculties
of adherence to complex regimens and to assess their concordance with therapy.
Method: Over a 3 week period HCPs replicated the average treatment of a
CF patient. I-neb systems were used to monitor adherence to inhaled therapy.
Electronic monitoring systems were used to record medication delivery, sham
physiotherapy was performed using incentive spirometry and a pedometer recorded
activity levels. Barriers to treatment and activity questionnaires were conducted at
the end of the study.
Results: Six HCPs were recruited. Nebuliser adherence was 69% (range 20.63–
96.83), medication adherence 15.8% (range 0−38). Activity levels showed 3 of the 6
were in the “low active” range (less than 7500 steps daily). Only 2 subjects
performed the recommended amount of weekly exercise. Signiﬁcant barriers to
concordance were time, socialisation, energy and willpower.
Conclusions: All subjects had an improved appreciation of the burden of care and
most thought the treatment burden greater than anticipated. Lack of time and timing
of therapies was identiﬁed as major barriers and generated greater empathy with
patients. Nebuliser usage was found to be easier than anticipated but cleaning was
a signiﬁcant barrier. This pilot data will be used to develop a training package
assisting HCP’s in understanding barriers to treatment and consider optimisation of
therapies. This could potentially improve patient health related quality of life and
concordance with treatment.
